Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
IFN-alpha 2 Antibody (N39), HRP, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP254398H
Description
IFN-alpha 2 Monoclonal specifically detects IFN-alpha 2 in Human samples. It is validated for ELISA.Specifications
IFN-alpha 2 | |
Monoclonal | |
HRP | |
PBS with No Preservative | |
IFNA2 | |
Purified recombinant human IFN-alpha 2 (Uniprot: P01563) | |
0.1 mL | |
Apoptosis, Biologically Active Proteins, Cytokine Research | |
Recognizes a protein of 16-27kDa, identified as human interferon-II) (IFN-(II). Its epitope maps between aa112-148 of IFN-II) (total aa172). This monoclonal antibody is specific for IFN-(II) and does not cross-react with IFN-(I). The site recognized by this monoclonal antibody is called site I and is responsible for the antiviral and anti-proliferative activities of IFN-(II). Epitopes of N27 and N39 monoclonal antibodys are different and represent a good combination of antibodies to set up an ELISA assay for the quantitation of IFN-(II) after viral infections. The IFN- family consists of 24 or more genes or pseudo-genes. IFN-II) is one of the two distinct families (I and II) of human IFN-. The -interferon are mainly produced by lymphocytes, monocytes, macrophages, and cell lines such as Namalwa and KG1 following induction by viruses, nucleic acids, and glucocorticoid hormones. They are involved in virus resistance on target cells, inhibition of cell proliferation, induction of cytokines and regulation of expression of MHC class I antigens. | |
Store at 4°C in the dark. |
ELISA | |
N39 | |
ELISA | |
alpha-2a interferon, IFNA, IFN-alpha-2, IFN-alphaA, INFA2, interferon alpha 2b, interferon alpha A, interferon alpha-2, Interferon alpha-A, interferon, alpha 2, LeIF A, MGC125764, MGC125765 | |
Mouse | |
Protein A or G purified | |
RUO | |
Primary | |
Human | |
IgG1 κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction